LANZOLLA, GIULIA Statistiche
LANZOLLA, GIULIA
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
2022-01-01 Gallo, D.; Mortara, L.; Veronesi, G.; Cattaneo, S. A. M.; Genoni, A.; Gallazzi, M.; Peruzzo, C.; Lasalvia, P.; Moretto, P.; Bruno, A.; Passi, A.; Pini, A.; Nauti, A.; Lavizzari, M. A.; Marino, M.; Lanzolla, G.; Tanda, M. L.; Bartalena, L.; Piantanida, E.
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy
2022-01-01 Lanzolla, G; Puccinelli, L; Giudetti, M; Comi, S; Menconi, F; Maglionico, M N; Posarelli, C; Figus, M; Marcocci, C; Marino, M
Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols
2022-01-01 Dallan, I.; Cristofani-Mencacci, L.; Fiacchini, G.; Benettini, G.; Picariello, M.; Lanzolla, G.; Lazzerini, F.; Rocchi, R.; Turri-Zanoni, M.; Menconi, F.; Sellari-Franceschini, S.; Marino, M.
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study
2022-01-01 Rotondo Dottore, G.; Torregrossa, L.; Lanzolla, G.; Mariotti, S.; Menconi, F.; Piaggi, P.; Cristofani Mencacci, L.; Posarelli, C.; Maglionico, M. N.; Dallan, I.; Figus, M.; Nardi, M.; Marcocci, C.; Basolo, F.; Marinò, M.
Sirolimus as a second-line treatment for Graves' orbitopathy
2022-01-01 Lanzolla, G; Maglionico, M N; Comi, S; Menconi, F; Piaggi, P; Posarelli, C; Figus, M; Marcocci, C; Marino', Michele
Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study
2021-01-01 Lanzolla, Giulia; Menconi, Francesca; Nicolì, Francesca; Posarelli, Chiara; Maglionico, Maria Novella; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
2021-01-01 Lanzolla, G.; Menconi, F.; Nicoli, F.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy
2021-01-01 Dottore, Giovanna Rotondo; Bucci, Ilaria; Lanzolla, Giulia; Dallan, Iacopo; Sframeli, Angela; Torregrossa, Liborio; Casini, Giamberto; Basolo, Fulvio; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele
Graves’ disease and Graves’ orbitopathy following COVID-19
2021-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
2021-01-01 Lanzolla, G.; Marino, M.; Marcocci, C.
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial
2021-01-01 Lanzolla, Giulia; Sabini, Elena; Leo, Marenza; Menconi, Francesca; Rocchi, Roberto; Sframeli, Angela; Piaggi, Paolo; Nardi, Marco; Marcocci, Claudio; Marinò, Michele
Statins: A New Hope on the Horizon of Graves Orbitopathy?
2021-01-01 Marino, M.; Lanzolla, G.; Marcocci, C.
Antioxidant Therapy in Graves’ Orbitopathy
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
2020-01-01 Lanzolla, Giulia; Vannucchi, Guia; Ionni, Ilaria; Campi, Irene; Sileo, Federica; Lazzaroni, Elisa; Marinò, Michele
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy
2020-01-01 Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis
2020-01-01 Rotondo Dottore, Giovanna; Leo, Marenza; Ricciardi, Roberta; Maestri, Michelangelo; Bucci, Ilaria; Lucchi, Marco; Melfi, Franca; Guida, Melania; De Rosa, Anna; Petrucci, Loredana; Ionni, Ilaria; Lanzolla, Giulia; Nicolì, Francesca; Mantuano, Michele; Ricci, Debora; Latrofa, Francesco; Mariotti, Stefano; Marcocci, Claudio; Marinò, Michele
Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Oxidative Stress in Graves Disease and Graves Orbitopathy
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study
2020-01-01 Lanzolla, G.; Ricci, D.; Nicoli, F.; Sabini, E.; Sframeli, A.; Brancatella, A.; Mantuano, M.; Dottore, G. R.; Bucci, I.; Figus, M.; Nardi, M.; Latrofa, F.; Marcocci, C.; Marino, M.
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases
2019-01-01 Lupi, Isabella; Brancatella, Alessandro; Cosottini, Mirco; Viola, Nicola; Lanzolla, Giulia; Sgrò, Daniele; Dalmazi, Giulia Di; Latrofa, Francesco; Caturegli, Patrizio; Marcocci, Claudio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment | 1-gen-2022 | Gallo, D.; Mortara, L.; Veronesi, G.; Cattaneo, S. A. M.; Genoni, A.; Gallazzi, M.; Peruzzo, C.; Lasalvia, P.; Moretto, P.; Bruno, A.; Passi, A.; Pini, A.; Nauti, A.; Lavizzari, M. A.; Marino, M.; Lanzolla, G.; Tanda, M. L.; Bartalena, L.; Piantanida, E. | |
| Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy | 1-gen-2022 | Lanzolla, G; Puccinelli, L; Giudetti, M; Comi, S; Menconi, F; Maglionico, M N; Posarelli, C; Figus, M; Marcocci, C; Marino, M | |
| Functional outcomes and complications in refractory dysthyroid optic neuropathy management: Experience with 3 different surgical protocols | 1-gen-2022 | Dallan, I.; Cristofani-Mencacci, L.; Fiacchini, G.; Benettini, G.; Picariello, M.; Lanzolla, G.; Lazzerini, F.; Rocchi, R.; Turri-Zanoni, M.; Menconi, F.; Sellari-Franceschini, S.; Marino, M. | |
| Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study | 1-gen-2022 | Rotondo Dottore, G.; Torregrossa, L.; Lanzolla, G.; Mariotti, S.; Menconi, F.; Piaggi, P.; Cristofani Mencacci, L.; Posarelli, C.; Maglionico, M. N.; Dallan, I.; Figus, M.; Nardi, M.; Marcocci, C.; Basolo, F.; Marinò, M. | |
| Sirolimus as a second-line treatment for Graves' orbitopathy | 1-gen-2022 | Lanzolla, G; Maglionico, M N; Comi, S; Menconi, F; Piaggi, P; Posarelli, C; Figus, M; Marcocci, C; Marino', Michele | |
| Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study | 1-gen-2021 | Lanzolla, Giulia; Menconi, Francesca; Nicolì, Francesca; Posarelli, Chiara; Maglionico, Maria Novella; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele | |
| Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study | 1-gen-2021 | Lanzolla, G.; Menconi, F.; Nicoli, F.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | |
| Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy | 1-gen-2021 | Dottore, Giovanna Rotondo; Bucci, Ilaria; Lanzolla, Giulia; Dallan, Iacopo; Sframeli, Angela; Torregrossa, Liborio; Casini, Giamberto; Basolo, Fulvio; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele | |
| Graves’ disease and Graves’ orbitopathy following COVID-19 | 1-gen-2021 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease | 1-gen-2021 | Lanzolla, G.; Marino, M.; Marcocci, C. | |
| Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial | 1-gen-2021 | Lanzolla, Giulia; Sabini, Elena; Leo, Marenza; Menconi, Francesca; Rocchi, Roberto; Sframeli, Angela; Piaggi, Paolo; Nardi, Marco; Marcocci, Claudio; Marinò, Michele | |
| Statins: A New Hope on the Horizon of Graves Orbitopathy? | 1-gen-2021 | Marino, M.; Lanzolla, G.; Marcocci, C. | |
| Antioxidant Therapy in Graves’ Orbitopathy | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy | 1-gen-2020 | Lanzolla, Giulia; Vannucchi, Guia; Ionni, Ilaria; Campi, Irene; Sileo, Federica; Lazzaroni, Elisa; Marinò, Michele | |
| Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy | 1-gen-2020 | Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | |
| Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis | 1-gen-2020 | Rotondo Dottore, Giovanna; Leo, Marenza; Ricciardi, Roberta; Maestri, Michelangelo; Bucci, Ilaria; Lucchi, Marco; Melfi, Franca; Guida, Melania; De Rosa, Anna; Petrucci, Loredana; Ionni, Ilaria; Lanzolla, Giulia; Nicolì, Francesca; Mantuano, Michele; Ricci, Debora; Latrofa, Francesco; Mariotti, Stefano; Marcocci, Claudio; Marinò, Michele | |
| Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Oxidative Stress in Graves Disease and Graves Orbitopathy | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study | 1-gen-2020 | Lanzolla, G.; Ricci, D.; Nicoli, F.; Sabini, E.; Sframeli, A.; Brancatella, A.; Mantuano, M.; Dottore, G. R.; Bucci, I.; Figus, M.; Nardi, M.; Latrofa, F.; Marcocci, C.; Marino, M. | |
| Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases | 1-gen-2019 | Lupi, Isabella; Brancatella, Alessandro; Cosottini, Mirco; Viola, Nicola; Lanzolla, Giulia; Sgrò, Daniele; Dalmazi, Giulia Di; Latrofa, Francesco; Caturegli, Patrizio; Marcocci, Claudio |